SCHEMBL4225366

SCHEMBL4225366

Clc1ccc2c3c(c4ccccc4cc13)C=C2

nearest known ligand 0.40

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
CYP2A6 P11509 4/20 0.40
CYP1A2 P05177 4/20 0.40
ALDH1A1 P00352 3/20 0.36
HIF1A Q16665 2/20 0.36
HSD17B10 Q99714 2/20 0.36
CYP1B1 Q16678 1/20 0.36
L3MBTL1 Q9Y468 2/20 0.32
P2RX4 Q99571 1/20 0.31
MAPT P10636 1/20 0.31
CES1 P23141 1/20 0.31
ERBB2 P04626 1/20 0.31
FYN P06241 1/20 0.31
MAOA P21397 1/20 0.31
ACHE P22303 1/20 0.31
AHR P35869 1/20 0.31
HPGD P15428 1/20 0.31
TSHR P16473 1/20 0.31
MAPK1 P28482 1/20 0.31
CASP1 P29466 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4855218 0.78 ALDH1A1 (0.46) CYP2A6CYP1A2ALDH1A1HIF1AHSD17B10
SCHEMBL29562021 0.74 CYP1A2 (0.47) CYP2A6CYP1A2ALDH1A1HIF1AHSD17B10
SCHEMBL26028 0.74 CYP1A2 (0.47) CYP2A6CYP1A2ALDH1A1HIF1AHSD17B10
SCHEMBL4847753 0.74 ALDH1A1 (0.42) CYP1A2ALDH1A1HIF1AHSD17B10CYP1B1
Triphenylene SCHEMBL22493025 0.73 CYP1A2 (0.46) CYP1A2ALDH1A1HIF1AHSD17B10CYP1B1
SCHEMBL4847656 0.72 ALDH1A1 (0.45) CYP2A6CYP1A2ALDH1A1HIF1AHSD17B10
SCHEMBL8764916 0.71 CYP1A2 (0.35) CYP2A6CYP1A2
SCHEMBL4850338 0.71 ALDH1A1 (0.48) CYP2A6CYP1A2ALDH1A1HIF1AHSD17B10
SCHEMBL6545899 0.71 ALDH1A1 (0.52) CYP2A6CYP1A2ALDH1A1HIF1AHSD17B10
SCHEMBL4851809 0.71 CYP1A2 (0.45) CYP2A6CYP1A2ALDH1A1HIF1AHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2069308-A2 AZONAFIDE DERIVED TUMOR AND CANCER TARGETING COMPOUNDS Government of the United States of America, Represented by the Secretary, Department of Health and Human Services (US) 2009-06-17 EP disclosed
WO-2008033891-A2 AZONAFIDE DERIVED TUMOR AND CANCER TARGETING COMPOUNDS GOVERNMENT OF THE UNITED STATES OF AMERICA, REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) 2008-03-20 WO disclosed